Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

SHARE BASED COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2015

A summary of the stock option activity and related information for the Plans for the six months ended June 30, 2015 is as follows:

					Weighted-
			Weighted-		Average		Aggregate
			Average		Remaining		Intrinsic
	Shares		Exercise Price		Contractual Term		Value
Outstanding at January 1, 2015		1,226,800	$	12.40		9.00
Grants		464,243	$	5.96		9.66	$	-
Exercised		-
Forfeitures or expirations		(83,400)	$	8.17
Outstanding at June 30, 2015		1,607,643	$	10.76		8.80	$	2,033,125

Vested and expected to vest at June 30, 2015		1,607,643	$	10.76		8.80	$	2,033,125
Exercisable at June 30, 2015		515,541	$	16.68		7.85	$	21,572

The assumptions used in the valuation of stock options granted during the six months ended June 30, 2015 and 2014 were as follows:

	Six Months			Six Months
	Ended			Ended
	June 30,			June 30,
	2015			2014
Risk-free interest rate		1.47% to 2.35	%		2.19% to 2.27	%
Expected term of option		6.0 to 9.91 years			6.0 years
Expected stock price volatility		85.05% to 92.13	%		97.56% to 100.73	%
Expected dividend yield		$0.0			$0.0

The following table summarizes the restricted stock activity for the six months ended June 30, 2015:

Restricted stock units as of January 1, 2015		-
Granted		42,000
Forfeited		-
Total Restricted stock units at June 30, 2015		42,000
Vested at June 30, 2015		-
Unvested restricted stock units as of June 30, 2015		42,000